Other studies have shown that apoptin interacts with and inhibits Abl/BCR-Abl1 kinase and downstream targets, like STAT5, CrkL, and c-myc in chronic myeloid leukemia (CML) [59]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.